Expertise

Kim is a Director on the Value & Evidence team at EVERSANA^® and supports numerous HEOR projects involving health economic modeling, evidence synthesis, and value communication to support reimbursement access across a range of therapeutic areas. At EVERSANA, Kim has been involved in leading the HEOR programs for multiple EU4 and UK submissions, as well as numerous Canadian HTA submissions. Specifically, Kim has experience in the development and adaptation of pharmacoeconomic models, systematic literature reviews, peer-reviewed manuscripts, value communication tools, clinical summaries, and advisory board meetings and workshops. Kim has experience working with both medical devices and pharmaceuticals in numerous therapeutic areas, including Alzheimer’s disease, chronic kidney disease, chronic rhinosinusitis with nasal polyps, multiple sclerosis, oncology, ophthalmology, peripheral artery disease, and several rare diseases. Before joining EVERSANA, Kim completed a postdoctoral fellowship at the Iovate/Muscletech Metabolism & Sports Science Lab at the University of Toronto where she led numerous clinical trials and collaborated with external research partners to develop product marketing and business strategies. Kim holds a PhD and MSc in Medical Sciences (specializing in Physiology and Pharmacology) from McMaster University, and an Honours BSc in Biomedical Sciences from the University of Guelph.